Mammograms may be beneficial for women over 75
According to a study published in Radiology, women over 75, a population not typically included in mammography screening effectiveness studies, may benefit from mammograms.
According to a study published in Radiology, women over 75, a population not typically included in mammography screening effectiveness studies, may benefit from mammograms.
Many older breast cancer patients with localized disease are taking drug treatments to prevent their cancer from returning, a new study finds. The research, covering a 7-year period, included more than 1,000 women, age 65 to 91 years, across the United States who had estrogen-positive breast cancer that had not spread.
A new antibody could dramatically boost strength and muscle mass in patients with cancer, COPD, sporadic inclusion body myositis, and in elderly patients with sarcopenia.
The largest cancer death rate was decrease seen among black men aged 40 to 49 years; no drop for white women aged over 80 was observed.
Although the occurrence of both cancer and Alzheimer’s disease increases exponentially with age, researchers have discovered an inverse relationship between the two illnesses.
A new immunomodulatory drug under FDA review significantly increased survival in persons with multiple myeloma, including older patients.
Heart failure is relatively common in older women undergoing breast cancer treatment, but trastuzumab therapy appears to raise the risk even more.
Gemtuzumab ozogamicin, discontinued here in 2010, reduced relapse risk and improved survival in Welsh patients with acute myeloid leukemia.
Administering radiotherapy after prostatectomy helped nearly two-thirds of users in a recent study remain free of prostate cancer after 10 years.
The breast cancer treatment brachytherapy, heralded for its low complication rates, actually results in more complications than whole-breast radiation 1 year after treatment.